Logopenic progressive aphasia
Logopenic progressive aphasia (LPA) is a type of aphasia characterized by difficulties in language expression and comprehension, despite preserved articulation and grammar. It is one of the three variants of primary progressive aphasia (PPA), the other two being semantic dementia and progressive nonfluent aphasia.
Symptoms[edit | edit source]
The main symptom of LPA is difficulty in retrieving words and names. This is often accompanied by pauses in speech. Patients may also have difficulty understanding complex sentences. However, unlike other forms of PPA, patients with LPA maintain the ability to produce grammatically correct sentences and their articulation remains intact.
Causes[edit | edit source]
LPA is caused by the degeneration of the left posterior perisylvian region of the brain, which includes the inferior parietal lobule and the posterior part of the superior temporal gyrus. This degeneration is often associated with Alzheimer's disease.
Diagnosis[edit | edit source]
Diagnosis of LPA is based on the presence of the characteristic symptoms and the exclusion of other causes of aphasia. Neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) can be used to identify the characteristic brain abnormalities associated with LPA.
Treatment[edit | edit source]
There is currently no cure for LPA. Treatment is focused on managing symptoms and improving quality of life. This may involve speech and language therapy, and in some cases, medication to slow the progression of the disease.
Prognosis[edit | edit source]
The prognosis for LPA is poor, with most patients experiencing a progressive decline in language abilities over time. However, the rate of progression can vary widely between individuals.
See also[edit | edit source]
Logopenic progressive aphasia Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD